Publications by authors named "N Splinter"

Background: There are very few documented reports in literature of cerebral venous sinus thrombosis (CVST) caused by immune-mediated heparin-induced thrombocytopenia (HIT). Further, there are very few reports of false negative serotonin release assays (SRAs) when testing for immune-mediated HIT.

Case Presentation: We present a case of a 60- year-old male with recent unfractionated heparin administration for venous thromboembolism prophylaxis, an elevated 4T score of 5 and acute CVST in which immune-mediated HIT was suspected.

View Article and Find Full Text PDF
Article Synopsis
  • Some patients with a serious condition called heparin-induced thrombocytopenia (HIT) need surgery, but using a blood thinner called heparin can be risky for them.
  • This study looked at whether a treatment combining two therapies, therapeutic plasma exchange (TPE) and intravenous immunoglobulin (IVIg), could help these patients safely use heparin during surgery.
  • The results showed that using TPE and IVIg helped the patient respond well to treatment, even though different tests gave varied results.
View Article and Find Full Text PDF

During torpor in a 13-lined ground squirrel heart rate and blood flow decrease, increasing the risk of blood clot formation. In response, cells involved in clotting called platelets are sequestered in the liver, stored in the cold for months, and released back into circulation upon arousal. This is in contrast to non-hibernating mammals, including humans, in which chilled platelets undergo cold storage lesions and phagocytosis, leading to rapid clearance from circulation post-transfusion.

View Article and Find Full Text PDF

Heparin-induced thrombocytopenia (HIT) is suspected much more often than it is confirmed. Technically simple platelet factor 4 (PF4)-polyanion enzyme-linked immunosorbent assays (ELISAs) are sensitive but nonspecific. In contrast, accurate functional tests such as the serotonin release assay, heparin-induced platelet activation assay, and PF4-dependent P-selectin expression assay require fresh platelets and have complex assay end points, limiting their availability to specialized reference laboratories.

View Article and Find Full Text PDF